Sutro Biopharma Inc.

NASDAQ: STRO · Real-Time Price · USD
0.92
0.04 (4.78%)
At close: Aug 18, 2025, 3:59 PM
0.88
-4.32%
After-hours: Aug 18, 2025, 05:53 PM EDT

Sutro Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
190.3M 69.27M 47.25M 30.41M
Short-Term Investments
126.59M 306.35M 287.11M 167.52M
Long-Term Investments
n/a n/a -32.02M 68.78M
Other Long-Term Assets
8.03M 4.44M 78.43M 2.53M
Receivables
8.62M 36.08M 7.12M 12.45M
Inventory
n/a n/a -11.67M n/a
Other Current Assets
17.8M 9.85M -20.35M n/a
Total Current Assets
343.31M 421.54M 309.47M 218.51M
Property-Plant & Equipment
35.87M 44.76M 51.06M 51.59M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
43.9M 49.19M 97.48M 122.89M
Total Assets
387.21M 470.74M 406.94M 341.41M
Account Payables
10.47M 9.44M 4.8M 6.01M
Deferred Revenue
69.78M 20.67M 16.76M 5.5M
Short-Term Debt
7.48M 4.06M 12.5M 9.38M
Other Current Liabilities
36.66M 38.47M 3.08M 11.42M
Total Current Liabilities
131.89M 93.75M 66.55M 41.74M
Long-Term Debt
180.81M 149.11M 3.77M 15.74M
Other Long-Term Liabilities
1.69M 1.69M 119K 146K
Total Long-Term Liabilities
210.71M 227.34M 123.35M 47.11M
Total Liabilities
342.61M 321.09M 189.9M 88.84M
Total Debt
23.15M 33.63M 50.43M 57.37M
Common Stock
83K 61K 58K 46K
Retained Earnings
-786.87M -559.41M -452.62M -333.41M
Comprehensive Income
39K 21K -618K -314K
Shareholders Equity
44.6M 149.65M 217.05M 252.56M
Total Investments
126.59M 306.35M 287.11M 236.3M